Edoxaban tosilate hydrate
A technology of p-toluenesulfonic acid and edoxaban, applied in organic chemistry, drug combination, blood diseases, etc., can solve the problem of weak inhibitory activity and achieve the effect of low impurity content
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 2
[0022] The formulation of embodiment 2-quality research and quality standard of compound of the present invention
[0023] The specific degradation impurities contained in edoxaban p-toluenesulfonate are impurities L, M, N, O. Among them, impurities L and M are hydrolysis products of edoxaban, which are easier to produce under alkaline conditions; impurities N and O are oxidation products.
[0024] According to the results of influencing factor tests and stability tests, the main impurities produced by self-produced and commercially available products during the storage process are oxidized impurities N and O, which will increase under high temperature and high humidity conditions.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com